Le Lézard
Classified in: Health, Science and technology
Subject: SCIENCE AND TECHNOLOGY

Align Technology Reaches Major Milestone for the iTero Element(R) Scanner With Over One Million Scans Submitted


SAN JOSE, CA and COLOGNE, GERMANY--(Marketwired - March 21, 2017) - Align Technology, Inc. (NASDAQ: ALGN) today announced that over one million scans have been submitted using the iTero Element® scanner since it was introduced in 2015 at the world's leading trade fair, International Dental Show conference in Cologne, Germany. The one millionth scan submitted was for an Invisalign patient being treated by Dr. Troy Moore, a general dental practitioner who has practiced for nearly 20 years in Amarillo, Texas.

"I am thrilled that my Invisalign case submission was the one millionth iTero Element scan," said Dr. Troy Moore. "As a general practitioner dentist, I was interested in increasing efficiencies in my practice and adopting Invisalign treatment more fully. I learned about the iTero Element scanner and how it could benefit my overall practice while attending the Reingage Invisalign course in 2016. I went from doing about six Invisalign case starts per quarter using PVS impressions, to doing over 60 per quarter by scanning patients with the iTero Element scanner. We also use the iTero Element scanner for our restorative cases, which produces a scan so accurate that restorations fit better than ever before and remakes from the laboratory are rarely needed. It is so user friendly, fast and easy to scan that my team refuses to use any other scanner than our iTero Element scanner."

"Reaching our one millionth iTero Element scan in less than two years from its launch, and having it be for an Invisalign patient is an exciting milestone for our company and demonstrates the trust and dedication our doctors share with Align to improve patient outcomes," said Raphael Pascaud, Align Technology Chief Marketing Officer. "The proven iTero digital technology enables doctors to perform high levels of restorative and orthodontic workflows that enhance their patient care and help them grow their practice."

About Align Technology, Inc.
Align Technology is the leader in modern clear aligner orthodontics that designs, manufactures and markets the Invisalign system, which provides dental professionals with a range of treatment options for adults and teenagers. The Company also offers the iTero 3D digital scanning system and services for orthodontic and restorative dentistry. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign clear aligners in 1998. Visit www.aligntech.com for more information.

For additional information about Invisalign treatment or to find an Invisalign provider in your area, please visit www.invisalign.com. For additional information about the iTero scanner, please visit www.itero.com


These press releases may also interest you

19 mai 2024
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

19 mai 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

19 mai 2024
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

19 mai 2024
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

19 mai 2024
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

19 mai 2024
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...



News published on and distributed by: